AVAH · Aveanna Healthcare Holdings Inc
$14.08
+1.59% last session
End-of-day data · close of 2026-09-11
Market cap
$3B
Enterprise value
$4B
Trailing P/E
11.0
Forward P/E
15.4
Dividend yield
—
Beta
1.97
Avg volume
3M
Employees
4K
Daily Change %
1.59%
5 Days Change
3.24%
10 Days Change
4.47%
30 Days Change
56.65%
60 Days Change
44.54%
Month to Day Change
4.16%
Year to Day Change
71.60%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — AVAH
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-08-28
Latest call per bank · past 12 months
Barclays
Overweight$15.00
+8.2% vs priceRBC Capital
Outperform$16.00
+15.4% vs priceUBS
Neutral$13.00
-6.2% vs priceJefferies
Buy$12.50
-9.8% vs priceJP Morgan
Neutral$10.00
-27.8% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-08-28 | Barclays | Maintains | Overweight | $9.50 → $15.00 |
| 2026-08-24 | Truist Securities | Maintains | Hold | $11.00 → $15.00 |
| 2026-08-24 | RBC Capital | Maintains | Outperform | $10.00 → $16.00 |
| 2026-08-14 | UBS | Maintains | Neutral | $8.00 → $13.00 |
| 2026-08-14 | Raymond James | Maintains | Strong Buy | $13.00 → $15.00 |
| 2026-08-14 | BMO Capital | Maintains | Outperform | $10.00 → $14.00 |
| 2026-07-14 | Truist Securities | Maintains | Hold | $9.00 → $11.00 |
| 2026-07-09 | Barclays | Maintains | Overweight | $9.00 → $9.50 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-09-11
- RSI (14): RSI is 72 — overbought territory; the recent run-up may be due for a pause.
- Price vs 50-day MA: Trading 26.9% above the 50-day MA ($11.10).
- Price vs 200-day MA: Trading 65.1% above the 200-day MA ($8.53).
- MA cross: The 50-day MA sits above the 200-day MA (golden-cross regime) — the longer-term trend points up.
- MACD (12,26,9): MACD histogram is negative (-0.07) — short-term momentum is fading.
- 52-week range: Price is within 5% of the 52-week high ($14.08).
AVAH Price Chart
Loading chart for AVAH…
Fundamentals
About Aveanna Healthcare Holdings Inc
Aveanna Healthcare Holdings Inc., a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities. The company operates through three segments: Private Duty Services (PDS), Home Health & Hospice (HHH), and Medical Solutions (MS). The PDS segment offers private duty nursing (PDN) services, which include in-home skilled nursing services to medically complex children and adults; nursing services in school settings in which its caregivers accompany patients to school; services to patients in its pediatric day healthcare centers; and non-clinical care, including support services and personal care services; and in-clinic and home-based therapy services, such as physical, occupational, and speech services. The HHH segment provides home health services, including in-home skilled nursing services; physical, occupational, and speech therapy services; and medical social and aide services, as well as hospice services for patients and their families when a life-limiting illness no longer responds to cure-oriented treatments. The MS segment offers enteral nutrition supplies and other products, including formulas, supplies, and pumps to adults and children delivered on a periodic or as-needed basis. The company was incorporated in 2016 and is headquartered in Atlanta, Georgia.
More in Medical Care Facilities
HCA
HCA Healthcare, Inc.
$93B -9.3% YTD
THC
Tenet Healthcare Corporation
$21B 35.4% YTD
FMS
Fresenius Medical Care AG
$12B -2.5% YTD
EHC
Encompass Health Corporation
$12B 15.1% YTD
DVA
DaVita Inc.
$12B 61.1% YTD
UHS
Universal Health Services, Inc.
$10B -19.1% YTD
ENSG
The Ensign Group, Inc.
$10B -1.3% YTD
CHE
Chemed Corp
$7B 21.7% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.